ArticleJournal of oncology2022

A Novel Tool to Predict the Overall Survival of High-Grade Osteosarcoma Patients after Neoadjuvant Chemotherapy: A Large Population-Based Cohort Study.

Zhangheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.